Evidence-Based Guide

Birth Control (Hormonal Contraception) Refills

How hormonal birth control works, types compared, missed pill protocols, drug interactions, warning signs, and the latest clinical guidelines.

Do you need a doctor's visit to refill hormonal birth control?

No routine exam is usually required. CDC's 2024 U.S. Selected Practice Recommendations say blood pressure should be measured before starting combined pills, patch or ring and that a pelvic examination is not necessary; among healthy patients, no examinations or tests are needed before progestin-only pills. CDC recommends providing up to a 1-year supply (for example, 13 pill packs) and notes that restricting the number of pill packs can be a barrier and might increase risk for pregnancy. Call a clinician or go to an emergency room right away for leg pain that will not go away, sudden shortness of breath, chest pain, a sudden change in vision, or a sudden, severe headache unlike your usual headaches (FDA patient labeling). A licensed clinician, by telehealth or in person, can review your history and decide whether a refill is appropriate.
Medically reviewed by Parth Bhavsar, MD. Updated July 14, 2026.

Key Takeaways

  • In 2022–2023, about 54% of U.S. females ages 15 to 49 were using contraception, and oral contraceptive pills were one of the most common methods (11.4%).[3]
  • CDC's 2024 U.S. Selected Practice Recommendations say a pelvic exam is not necessary before starting combined pills, patch or ring, but blood pressure should be measured first. Among healthy patients, no exams or tests are needed before starting progestin-only pills.[6][8]
  • CDC's guidance covers extended or continuous use (few or no hormone-free days) and how to manage the spotting that is common in the first 3–6 months.[6]
  • The 2024 U.S. Medical Eligibility Criteria place broad-spectrum antibiotics in Category 1 (no restriction) for every hormonal method. Rifampin, rifabutin and certain anticonvulsants are Category 3 for pills, patch and ring, and St. John's wort is Category 2.[11]
  • Know the ACHES warning signs for serious complications: Abdominal pain (severe), Chest pain, Headaches (severe), Eye problems, Severe leg pain. Get care right away if they occur.[16]
Editorial medical illustration representing Birth Control (Hormonal Contraception) Refills
Birth Control (Hormonal Contraception) Refills: an evidence-based overview from the TeleDirectMD medical team.

I refill hormonal birth control prescriptions more often than almost any other medication in clinical practice. It should be one of the simplest things in medicine: a patient who is doing well on their method needs a continuation of the same prescription. Yet I'm continually surprised by how many barriers, misconceptions, and unnecessary hoops patients encounter when trying to maintain something as fundamental as contraceptive continuity.

In 2022–2023, 54.3% of U.S. females ages 15 to 49 were currently using contraception, and oral contraceptive pills were among the most common methods, used by 11.4%.[3] Gaps in supply matter. CDC notes that restricting the number of pill packs prescribed or dispensed can be a barrier and might increase the risk of pregnancy, and that the more pill packs provided, up to 13 cycles, the higher the continuation rates.[6]

This guide is written to give you the same level of detail I'd share in a thorough clinic visit: how these medications actually work, what the latest guidelines say about safe prescribing, how to handle missed pills, which drug interactions are real versus myth, and, critically, which warning signs should send you to an emergency room. Whether you're renewing a longstanding prescription or considering hormonal contraception for the first time, this is the evidence you need to make informed decisions with your clinician.

How Hormonal Birth Control Works

Hormonal contraceptives deliver synthetic versions of the hormones your body naturally produces (an estrogen, a progestin, or both) to interrupt the reproductive cycle. Understanding these mechanisms helps explain why the medications work well when used consistently, and why gaps in use create vulnerability.

The Three Mechanisms of Action

1. Ovulation suppression. This is the primary mechanism. FDA labeling states that combination oral contraceptives prevent pregnancy primarily by suppressing ovulation, and that combined hormonal contraceptives act by suppressing gonadotropins, the pituitary signals that trigger ovulation.[13][5]

2. Cervical mucus changes. FDA labeling for combined hormonal contraceptives also describes changes in the cervical mucus that make it harder for sperm to enter the uterus.[5]

3. Endometrial changes. The same labeling describes changes in the uterine lining (endometrium) that reduce the likelihood of implantation.[5]

Estrogen vs. Progestin: Why It Matters

Combined methods (pill, patch, ring) contain both an estrogen and a progestin. Combined oral contraceptives increase the risk of venous thromboembolism (VTE), although VTE is rare in young women of reproductive age.[4] Progestin-only methods (progestin-only pill, implant, hormonal IUD, injection) contain no estrogen. In the 2024 U.S. Medical Eligibility Criteria, progestin-only pills are Category 2 for a history of blood clots and Category 1 for migraine with aura, while combined methods are Category 3 or 4 for a history of blood clots and Category 4 for migraine with aura.[10][9]

Types of Hormonal Contraception Available for Refill

When patients come in for a birth control refill, I want to make sure they're on the method that best fits their lifestyle, medical history, and preferences. Here's a comparison of four commonly refilled hormonal methods, the ones you're most likely to discuss at a routine refill visit.

Method Typical-Use Efficacy Dosing Schedule Pros Cons
Combined Oral Contraceptive (COC) About 93% (7% typical-use failure rate)[12] One pill daily; packs include hormone-free (placebo) days, or the pills can be used with infrequent or no hormone-free days[6] Many formulations available; can be used in an extended or continuous pattern Must remember daily; missing active pills next to the hormone-free interval is a particularly risky time[6]; increased VTE risk[4]; contraindicated in people over 35 who smoke[13]
Progestin-Only Pill (POP / "mini-pill") About 93% (7% typical-use failure rate)[12] One pill daily; norethindrone or norgestrel pills count as missed when more than 3 hours late; drospirenone pills count as late when less than 24 hours late[8] No estrogen; Category 1 for migraine with aura and Category 2 for a history of blood clots in the 2024 U.S. MEC[10] Norethindrone and norgestrel pills have a narrow timing window[8]
Transdermal Patch About 93% (7% typical-use failure rate)[12] A new patch each week for 3 weeks; week 4 is patch-free[5] Weekly rather than daily dosing May be less effective in people who weigh 198 lbs (90 kg) or more; application site reactions are among the most common side effects; contraindicated in people over 35 who smoke[5]
Vaginal Ring About 93% (7% typical-use failure rate)[12] NuvaRing: one ring stays in for 3 weeks, then a 1-week break[14]; Annovera: one ring provides contraception for thirteen 28-day cycles (1 year)[15] Self-inserted ring rather than a daily pill Vaginitis and vaginal secretion were among the most common adverse events in NuvaRing trials; NuvaRing is stored refrigerated before dispensing[14]

CDC lists a typical-use failure rate of 7% for the combined pill, the progestin-only pill, the patch and the ring.[12] All four depend on the user taking, changing or replacing them on schedule, which is why I spend time at refill visits asking patients how the method is fitting into their routine. If adherence is proving difficult, it may be time to discuss a less user-dependent method like an IUD or implant rather than continuing to refill a method that isn't being used consistently.

What's Changed: Latest Guidelines (2024 CDC Updates)

In 2024, CDC published new editions of the U.S. Medical Eligibility Criteria (U.S. MEC) and the U.S. Selected Practice Recommendations (U.S. SPR), each replacing its 2016 version. These documents have practical implications for how we manage contraceptive refills.[1][2]

Key Guideline Changes for Refill Visits

No routine exam required. The 2024 U.S. SPR states that most patients need no or very few examinations or tests before starting a contraceptive method.[2] For combined hormonal methods, blood pressure should be measured before starting; a pelvic examination is not necessary, and a clinical breast exam and cervical cytology are Class C, meaning they do not contribute substantially to safe and effective use.[6] Among healthy patients, no examinations or tests are needed before starting progestin-only pills.[8]

Progestin-Only Methods: Broader Safety Profile Confirmed

In the 2024 U.S. MEC, progestin-only pills are Category 1 for adequately controlled hypertension and for blood pressure of 140–159 systolic or 90–99 diastolic, and Category 2 for systolic 160 or higher or diastolic 100 or higher. They are Category 2 for a history of blood clots (DVT/PE) and Category 1 for migraine with aura.[10] Combined methods are Category 3 for adequately controlled hypertension or blood pressure of 140–159 systolic or 90–99 diastolic, Category 4 for systolic 160 or higher or diastolic 100 or higher, Category 3 or 4 for a history of blood clots, and Category 4 for migraine with aura.[9] Category 1 means no restriction, Category 2 means the advantages generally outweigh the risks, Category 3 means the risks usually outweigh the advantages, and Category 4 means an unacceptable health risk.[1] This is an important point because many patients are told they need an "annual physical" before their birth control can be refilled. That is not what CDC recommends: most patients need no or very few examinations or tests before starting a method.[2]

Extended and Continuous Cycling: A Recognized Option

CDC's 2024 U.S. SPR addresses combined methods used for an extended period with infrequent or no hormone-free days.[6] Extended cycling means taking active hormones for longer before a hormone-free interval. Continuous cycling means eliminating the hormone-free interval entirely.

Before starting extended or continuous use, CDC advises counseling about changes in bleeding patterns: spotting or bleeding is common in the first 3–6 months, is generally not harmful, and usually improves with continued use. If bothersome bleeding occurs, CDC's approach is a hormone-free interval of 3–4 consecutive days, but not during the first 21 days of continuous or extended use and not more than once per month.[6]

12-Month Prescribing

CDC recommends providing or prescribing up to a 1-year supply of pills (for example, 13 28-day pill packs) at the initial and return visits. The more pill packs provided, up to 13 cycles, the higher the continuation rates, and a greater number of packs was associated with fewer pregnancies. Restricting the number of pill packs distributed or prescribed can be a barrier and might increase risk for pregnancy.[6] If your pharmacy or insurance is limiting you to 1–3 month supplies, that limit does not come from CDC's medical recommendations.

Decision Framework: Routine Refill, Talk to Your Doctor, or Seek Emergency Care

Not every refill visit is the same. Here's the framework used in practice to help patients understand what level of care their situation requires:

Scenario Recommended Action Rationale
Doing well on current method: no new symptoms, stable blood pressure, no new medications or medical conditions Routine refill; can often be handled via telemedicine or pharmacy renewal Among healthy patients, few examinations or tests are needed before combined methods and none before progestin-only pills[6][8]
Persistent side effects: breakthrough bleeding beyond 3 months, ongoing mood changes, headaches, decreased libido Schedule a visit to discuss dose adjustment or method switch Side effects that persist may warrant a change in formulation or method type
New medical condition: new migraine with aura, new high blood pressure, upcoming major surgery with prolonged immobilization, smoking at age 35 or older Medical evaluation required before continuing combined hormonal methods These are Category 3 or 4 for combined methods in the 2024 U.S. MEC; a progestin-only or non-hormonal method may be needed[9]
New medication started: anticonvulsant, rifampin or rifabutin, certain HIV antiretrovirals, St. John's wort Contact your prescriber; you may need a back-up method or a contraceptive change FDA labeling lists enzyme inducers that may decrease hormonal contraceptive effectiveness and advises back-up contraception for 28 days after stopping one[5]
ACHES warning signs: severe abdominal pain, chest pain, sudden severe headache, vision changes, severe leg pain or swelling Seek emergency care immediately FDA patient labeling says to call your provider or go to a hospital emergency room right away for symptoms such as these[13]

Common Side Effects vs. Warning Signs

One of the most important things I discuss with patients starting or continuing hormonal contraception is the distinction between expected side effects that will likely settle on their own and warning signs that require immediate medical attention. Confusing the two leads either to unnecessary panic or, more dangerously, to ignoring symptoms that demand urgent evaluation.

Expected Side Effects (Often Improve With Continued Use)

  • Breakthrough bleeding or spotting: The most common reason patients call about their birth control. Spotting or bleeding is common, especially in the first 3–6 months of extended or continuous use; it is generally not harmful and usually improves with continued use.[6]
  • Nausea: Nausea and vomiting are among the most common side effects reported in trials of the patch.[5]
  • Breast tenderness: Breast symptoms are also among the most common side effects reported with the patch.[5]
  • Headaches: Headache is a common side effect of combined methods.[5][14] Ordinary headaches are different from a sudden, severe headache unlike your usual headaches, which needs emergency care.[13]
  • Mood changes: Some patients report mood fluctuations, irritability, or decreased libido. Individual responses vary, so tell your clinician if this happens.
  • Weight: A Cochrane review of randomized trials found no large effect of combination pills or the combination patch on weight (see the FAQ below).[17]

When Side Effects Cross the Line

Contact your physician if any of these persist beyond 3 months of consistent use, significantly affect your quality of life, or represent a new pattern that is different from your initial adjustment period. A change in formulation (a different progestin, a different estrogen dose, or a non-oral route) may resolve persistent side effects without abandoning hormonal contraception altogether.

Missed Pill Protocols: Clear Guidance by Pill Type

Missed pills are a common problem. CDC's 2024 guidance on what to do is clear and practical, and it differs by pill type.[6][8]

Combined Oral Contraceptives (COCs)

One pill late (less than 24 hours since it should have been taken) or one pill missed (24 to <48 hours):

  • Take the late or missed pill as soon as possible.
  • Continue the remaining pills at the usual time, even if it means taking two pills on the same day.
  • No additional contraceptive protection is needed.
  • Emergency contraception is not usually needed but may be considered (other than ulipristal acetate) if pills were missed earlier in the cycle or in the last week of the previous cycle.[6]

Two or more consecutive pills missed (≥48 hours since a pill should have been taken):

  • Take the most recent missed pill as soon as possible. Discard any other missed pills.
  • Continue the remaining pills at the usual time, even if it means taking two pills on the same day.
  • Use condoms or abstain until hormonal pills have been taken for 7 consecutive days.
  • If pills were missed in the last week of hormonal pills: skip the hormone-free interval by finishing the hormonal pills in the current pack and starting a new pack the next day.
  • If pills were missed in the first week and unprotected intercourse occurred in the previous 5 days: consider emergency contraception (other than ulipristal acetate).[6]
Why the Timing Around the Placebo Week Matters Most

CDC states that seven days of continuous use is needed to reliably prevent ovulation. Missing active pills directly before or after the placebo or pill-free interval extends the hormone-free interval, which CDC describes as a particularly risky time to miss pills. That is why CDC recommends skipping the hormone-free interval if pills are missed in the last week of hormonal pills.[6]

Progestin-Only Pills (POPs)

Norethindrone or norgestrel POPs: These have a very narrow timing window. A dose counts as missed if it is more than 3 hours late. Take one pill as soon as possible, then use condoms or abstain until pills have been taken correctly, on time, for 2 consecutive days. Consider emergency contraception (other than ulipristal acetate) if you have had unprotected intercourse.[8]

Drospirenone POPs: A dose is late if less than 24 hours have passed and missed if 24 hours or more have passed. For one late or missed pill (less than 48 hours), take it as soon as possible; no additional contraceptive protection is needed. For two or more consecutive missed pills (48 hours or more), take the last missed pill as soon as possible, use condoms or abstain until hormonal pills have been taken for 7 consecutive days, and consider emergency contraception (other than ulipristal acetate) if pills were missed in the first week and unprotected intercourse occurred in the previous 5 days.[8]

Drug Interactions to Know

This is one of the areas where misinformation causes the most unnecessary anxiety. Let me be direct: most common antibiotics are not a problem for hormonal birth control. CDC's 2024 U.S. MEC places broad-spectrum antibiotics, antifungals and antiparasitics in Category 1 (no restriction) for every hormonal method.[11]

The Antibiotic Myth

The exception is the rifamycin class. Rifampin and rifabutin are Category 3 for combined methods and progestin-only pills in the 2024 U.S. MEC.[11] CDC notes that although the interaction with progestin-only pills is not harmful, it is likely to reduce their effectiveness.[10] For other antibiotics, the MEC sets no restriction, so routine courses of common antibiotics do not call for back-up contraception on that basis.[11]

Real Interactions That Matter

Medication Mechanism What to Do
Rifamycins (rifampin, rifabutin) Enzyme inducers that may decrease the effectiveness of hormonal contraceptives[5] Category 3 for pills, patch and ring in the 2024 U.S. MEC; the copper IUD is Category 1.[11] FDA labeling for combined methods advises an alternative or back-up method while taking an enzyme inducer and for 28 days after stopping it.[5]
Certain anticonvulsants (phenytoin, carbamazepine, barbiturates, primidone, topiramate, oxcarbazepine) Enzyme induction may decrease hormonal contraceptive effectiveness.[5] Lamotrigine is classified separately: Category 3 with combined methods and Category 1 with progestin-only pills.[11] Category 3 for pills, patch and ring; Category 1 for copper and levonorgestrel IUDs and for the injection.[11] Discuss options with your neurologist and prescriber jointly.
St. John's wort (Hypericum perforatum) A known strong inducer of the CYP3A4 enzyme; limited evidence shows more breakthrough bleeding and possible ovulation when taken with combined pills[7] Category 2 with pills, patch and ring in the 2024 U.S. MEC.[11] Tell your prescriber if you take it; FDA labeling lists products containing St. John's wort among those that call for back-up contraception for 28 days after stopping.[5]
Certain HIV antiretrovirals Effects vary by drug In the 2024 U.S. MEC, most listed antiretrovirals are Category 1 with combined methods, and some (such as efavirenz and ritonavir-boosted atazanavir, darunavir or fosamprenavir) are Category 2.[9] CDC revised this guidance in 2024, so review your specific regimen with your prescriber.[1]
Griseofulvin (antifungal) Listed in FDA labeling among drugs that may decrease hormonal contraceptive effectiveness[5] Use an alternative or back-up method during treatment and for 28 days after the last dose.[5]

The practical takeaway: whenever you start a new medication, prescription or over-the-counter, including herbal supplements, check with your pharmacist or prescriber about potential interactions with your contraceptive. This is especially important for anticonvulsants and herbal products, which patients often don't think to mention.

Red Flags: When to Seek Emergency Care

Serious complications of hormonal contraception are rare but real. Venous thromboembolism (VTE), meaning a deep vein thrombosis (DVT) or pulmonary embolism (PE), is a key safety concern with estrogen-containing methods. The American Society for Reproductive Medicine puts VTE incidence at 3–15 per 10,000 woman-years in users of combined hormonal contraception, compared with 1–5 per 10,000 in non-users, 5–20 per 10,000 during pregnancy, and 40–65 per 10,000 after delivery.[4] But "rare" is not the same as "zero," and recognizing the warning signs early can be lifesaving.

FDA labeling states that VTE risk is highest during the first year of use and when restarting hormonal contraception after a break of 4 weeks or longer, another reason why continuity of refills matters.[5] Smoking (particularly more than 15 cigarettes a day), obesity, and inherited clotting disorders such as factor V Leiden add to the risk.[4] Major surgery with prolonged immobilization is Category 4 for combined methods.[9]

ACHES: Emergency Warning Signs for Hormonal Contraception Users
  • A: Abdominal pain: severe, or unusual for you.[16] FDA patient labeling also says to call your provider if your skin or eyes turn yellow.[13]
  • C: Chest pain: sharp, crushing or heavy chest pain, or sudden shortness of breath.[16][13]
  • H: Headaches: a sudden, severe headache unlike your usual headaches, especially with weakness or numbness in an arm or leg or trouble speaking.[13] Migraine with aura is Category 4 for estrogen-containing methods.[9]
  • E: Eye problems: blurry vision, loss of vision, or flashing lights.[16] FDA patient labeling lists a sudden change in vision or blindness.[13]
  • S: Severe leg pain: sudden pain in the calf or thigh, with redness, heat or swelling, or leg pain that will not go away.[16][13]

If you experience any ACHES symptom, get care right away. FDA patient labeling says to call your healthcare provider or go to a hospital emergency room right away for these symptoms, and patient guidance advises stopping your pills and talking to your provider. Do not wait to see if it improves.[13][16]

I want to be transparent about perspective here: by these estimates, the VTE risk with combined hormonal contraception (3–15 per 10,000 woman-years) overlaps the risk during pregnancy (5–20 per 10,000) and is far below the risk after delivery (40–65 per 10,000).[4] This does not minimize the importance of recognizing warning signs, but it does mean that fear of rare side effects should not drive patients away from effective contraception when they need it. The goal is informed vigilance, not avoidance.

Frequently Asked Questions

For many patients, yes. CDC's 2024 U.S. Selected Practice Recommendations say most patients need no or very few examinations or tests before starting a contraceptive method.[2] For combined hormonal methods, blood pressure should be measured before starting, and a pelvic examination is not necessary.[6] Among healthy patients, no examinations or tests are needed before starting progestin-only pills.[8] Whether a video visit is enough depends on your health history, so tell your clinician about any new conditions or medications.

For most antibiotics, no. CDC's 2024 U.S. Medical Eligibility Criteria place broad-spectrum antibiotics in Category 1 (no restriction) for every hormonal method. The exception is the rifamycins (rifampin and rifabutin), which are Category 3 with pills, patch and ring. Other medicines that matter include certain anticonvulsants (phenytoin, carbamazepine, barbiturates, primidone, topiramate and oxcarbazepine) and St. John's wort.[11] FDA labeling for combined methods advises back-up contraception while taking an enzyme inducer and for 28 days after stopping it.[5]

CDC's 2024 U.S. Selected Practice Recommendations include guidance for using combined methods with infrequent or no hormone-free days. Spotting or bleeding is common in the first 3–6 months, is generally not harmful, and usually improves with continued use. If bleeding is bothersome, CDC's approach is a hormone-free interval of 3–4 consecutive days, but not during the first 21 days of extended or continuous use and not more than once per month.[6] Ask your prescriber how to adapt your specific pill pack.

If one combined pill is late or missed (less than 48 hours since it should have been taken), take it as soon as possible and continue the rest at the usual time, even if that means taking two pills on the same day. No additional contraceptive protection is needed. Missing two or more consecutive pills (48 hours or more) calls for condoms or abstinence until hormonal pills have been taken for 7 consecutive days, and CDC describes missing active pills directly before or after the hormone-free interval as a particularly risky time.[6] Norethindrone and norgestrel progestin-only pills count as missed when more than 3 hours late.[8]

Bleeding changes are common early on. CDC notes that spotting or bleeding is common in the first 3–6 months of extended or continuous use and usually improves with continued use.[6] I generally counsel patients to give a new method about three cycles before deciding it isn't working for them, provided there are no warning signs (see the ACHES list above). If side effects persist or significantly affect your quality of life, switching to a different formulation is reasonable to discuss with your prescriber.

This is one of the most common concerns I hear. A Cochrane review of 49 randomized trials found that the trials with a placebo or no-intervention group did not find evidence that combination pills or the combination skin patch cause weight change, and concluded that no large effect was evident, although the evidence was insufficient to determine the effect with certainty.[17] The review did not cover the injection (DMPA), so weight questions about that method are worth discussing separately with your clinician.

References

  1. Nguyen AT, Curtis KM, Tepper NK, et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. MMWR Recomm Rep. 2024;73(No. RR-4):1–126. Centers for Disease Control and Prevention. Accessed November 7, 2026. https://www.cdc.gov/mmwr/volumes/73/rr/rr7304a1.htm
  2. Curtis KM, Nguyen AT, et al. U.S. Selected Practice Recommendations for Contraceptive Use, 2024. MMWR Recomm Rep. 2024;73(3):1–77. Centers for Disease Control and Prevention. Accessed November 7, 2026. https://www.cdc.gov/mmwr/volumes/73/rr/rr7303a1.htm
  3. Daniels K, Abma JC. Current Contraceptive Status Among Females Ages 15–49: United States, 2022–2023. NCHS Data Brief No. 539. National Center for Health Statistics; August 2025. Accessed November 7, 2026. https://www.cdc.gov/nchs/products/databriefs/db539.htm
  4. Practice Committee of the American Society for Reproductive Medicine. Combined hormonal contraception and the risk of venous thromboembolism: a guideline. Fertil Steril. 107(1):43–51. Published online October 25, 2016. https://doi.org/10.1016/j.fertnstert.2016.09.027
  5. U.S. Food and Drug Administration. Xulane (norelgestromin and ethinyl estradiol transdermal system) prescribing information. Revised March 2022. DailyMed, National Library of Medicine. Accessed November 7, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f7848550-086a-43d8-8ae5-047f4b9e4382
  6. Centers for Disease Control and Prevention (CDC). Combined Hormonal Contraceptives. U.S. Selected Practice Recommendations for Contraceptive Use, 2024. Page dated November 19, 2024. Accessed November 7, 2026. https://www.cdc.gov/contraception/hcp/usspr/combined-hormonal-contraceptives.html
  7. Berry-Bibee EN, Kim MJ, Tepper NK, Riley HEM, Curtis KM. Co-administration of St. John's wort and hormonal contraceptives: a systematic review. Contraception. 2016;94(6):668–677. https://pmc.ncbi.nlm.nih.gov/articles/PMC11283811/
  8. Centers for Disease Control and Prevention (CDC). Progestin-Only Pills. U.S. Selected Practice Recommendations for Contraceptive Use, 2024. Page dated November 19, 2024. Accessed November 7, 2026. https://www.cdc.gov/contraception/hcp/usspr/progestin-only-pills.html
  9. Centers for Disease Control and Prevention (CDC). Appendix D: Classifications for Combined Hormonal Contraceptives. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. Page dated November 19, 2024. Accessed November 7, 2026. https://www.cdc.gov/contraception/hcp/usmec/combined-hormonal-contraceptives.html
  10. Centers for Disease Control and Prevention (CDC). Appendix C: Classifications for Progestin-Only Contraceptives. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. Page dated November 19, 2024. Accessed November 7, 2026. https://www.cdc.gov/contraception/hcp/usmec/progestin-only-contraceptives.html
  11. Centers for Disease Control and Prevention (CDC). Summary Chart of U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. Accessed November 7, 2026. https://www.cdc.gov/contraception/media/pdfs/2024/07/us-mec-summary-chart-color-508.pdf
  12. Centers for Disease Control and Prevention (CDC). Contraception and Birth Control Methods. Page dated August 6, 2024. Accessed November 7, 2026. https://www.cdc.gov/contraception/about/index.html
  13. U.S. Food and Drug Administration. Altavera (levonorgestrel and ethinyl estradiol tablets) prescribing information and patient information. Rev. February 2023. DailyMed, National Library of Medicine. Accessed November 7, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4701e72b-6378-a771-fb88-1b703031a8bc
  14. U.S. Food and Drug Administration. NuvaRing (etonogestrel/ethinyl estradiol vaginal ring) prescribing information. Revised February 2012. DailyMed, National Library of Medicine. Accessed November 7, 2026. https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=7e6f14df-1ce5-43fa-ad21-90bc4d74bc6c
  15. U.S. Food and Drug Administration. Annovera (segesterone acetate and ethinyl estradiol vaginal system) prescribing information. Revised August 2024. DailyMed, National Library of Medicine. Accessed November 7, 2026. https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=eb18194f-2021-41fa-8bdf-31e0c0eb646b&type=display
  16. South Carolina Department of Public Health. Combined Oral Contraceptives (birth control pills). Patient handout 00354-ENG-CR, revision 6/25. Accessed November 7, 2026. https://dph.sc.gov/sites/scdph/files/Library/00354-ENG-CR.pdf
  17. Gallo MF, Lopez LM, Grimes DA, Carayon F, Schulz KF, Helmerhorst FM. Combination contraceptives: effects on weight. Cochrane Database Syst Rev. 2014;(1):CD003987. https://doi.org/10.1002/14651858.CD003987.pub5

About the Author

Parth Bhavsar, MD

Dr. Bhavsar is a board-certified family medicine physician and founder of TeleDirectMD. Hormonal contraception refills are one of the most frequent services in his telemedicine practice, serving patients across 40+ U.S. states + DC. He is fluent in English, Hindi, Gujarati, and Urdu.

Medically reviewed by Parth Bhavsar, MD. Last reviewed March 8, 2026 · Updated: May 2026